Heart Lung Machine Registry (HeaLMe)
Post-Market Clinical Follow-up Registry to Evaluate the Safety and Performance of the HL 40 Heart Lung Machine and the Temperature Probes in Patients Undergoing Cardiac / Thoracic / Vascular Surgery
Sponsor: Maquet Cardiopulmonary GmbH
Terminated
The index device HL 40 has been discontinued
Other Cardiac Surgery trials with similar outcome
A observational or N/A phase clinical study on Cardiac Surgery and Cardiopulmonary Bypass, this trial is terminated or withdrawn. The trial is conducted by Maquet Cardiopulmonary GmbH and has accumulated 5 data snapshots since 2023. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
5 versions recorded-
Jan 2026 — Present [monthly]
Terminated
Status: Recruiting → Terminated
-
Sep 2024 — Jan 2026 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
May 2024 — Jul 2024 [monthly]
Recruiting
-
Jan 2024 — May 2024 [monthly]
Recruiting
First recorded
Dec 2023
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Maquet Cardiopulmonary GmbH
- NAMSA
For direct contact, visit the study record on ClinicalTrials.gov .